发明名称 Pyrimidine compounds for the inhibition of Eph receptors and for the treatment of cancer
摘要 Disclosed is a compound of Formula I wherein one of A1,A2 or A3 is N, and the others are independently selected from CH or N; R1 is a (1-4C)alkyl group which is optionally substituted by one or more substituent groups selected from -OR5 (wherein R5 is selected from hydrogen or (1-2C)alkyl), cyano, halo, or ?NR6R7 (where R6 and R7 are independently selected from hydrogen, (1-2C)alkyl or (1?2C)alkanoyl); n is 0, 1, 2 or 3; each R2 group present is independently selected from (1-2C)alkyl, (1-2C)alkoxy, fluoro, chloro, cyano, hydroxy(1-2C)alkyl, or a group of sub-formula: -Q-R8 Specific examples of a compound of Formula I include N'-(3-chloro-2,4-difluoro-phenyl)-N-(4-chloro-6-morpholin-4-yl-pyridin-2-yl)-N'-methylpyrimidine- 2,4-diamine, and N'-(3-chloro-2,4-difluoro-phenyl)-N-(2,6-dimorpholin-4-ylpyridin-4-yl)-N'-methylpyrimidine-2,4-diamine; Also disclosed is the use of the compound of Formula I for treating cancer.
申请公布号 NZ581397(A) 申请公布日期 2012.02.24
申请号 NZ20080581397 申请日期 2008.04.25
申请人 ASTRAZENECA AB 发明人 DUCRAY, RICHARD;BARLAAM, BERNARD, CHRISTOPHE
分类号 C07D401/12;A61K31/506;A61P35/00;C07D403/12 主分类号 C07D401/12
代理机构 代理人
主权项
地址